CEL-SCI Corporation  

(Public, NYSEMKT:CVM)   Watch this stock  
Find more results for CVM
1.27
-0.02 (-1.55%)
Apr 23 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.26 - 1.33
52 week 0.53 - 3.09
Open 1.30
Vol / Avg. 543,362.00/1.85M
Mkt cap 85.17M
P/E     -
Div/yield     -
EPS -0.34
Shares 67.06M
Beta 1.66
Inst. own 10%
Feb 11, 2014
CEL-SCI at Biotechnology Industry Organization CEO & Investor Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -3831.02% -5746.93%
Operating margin -5245.10% -12450.36%
EBITD margin - -12063.59%
Return on average assets -97.57% -68.17%
Return on average equity -200.50% -134.48%
Employees 43 -
CDP Score - -

Address

Suite 802, 8229 Boone Boulevard
VIENNA, VA 22182
United States - Map
+1-703-5069460 (Phone)
+1-703-5069471 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Officers and directors

Maximilian de Clara President, Director
Age: 82
Bio & Compensation  - Reuters
Geert R. Kersten Esq. Chief Executive Officer, Treasurer, Director
Age: 53
Bio & Compensation  - Reuters
Patricia B. Prichep Senior Vice President - Operations, Corporate Secretary
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John Cipriano Senior Vice President - Regulatory Affairs
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Daniel H. Zimmerman Ph.D. Senior Vice President - Research, Cellular Immunology
Age: 71
Bio & Compensation  - Reuters
Eyal Talor Ph.D. Chief Scientific Officer
Age: 56
Bio & Compensation  - Reuters
Alexander G. Esterhazy Independent Director
Age: 70
Bio & Compensation  - Reuters
C. Richard Kinsolving Ph.D. Independent Director
Age: 76
Bio & Compensation  - Reuters
Peter R. Young Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters